Ergoteles’s Intersect ENT, Inc XENT Stock Holding History

Ergoteles’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-333,564	Closed	-$9.34M	–	2151
2022 Q1	$9.34M	Buy	333,564 +20,193	+6%	+$553K	0.35%	65
2021 Q4	$8.56M	Buy	313,371 +59,170	+23%	+$1.6M	0.33%	67
2021 Q3	$6.91M	Buy	+254,201	New	+$6.29M	0.25%	110

Ergoteles's XENT Position: Q2 2022 in Review

Ergoteles sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 333,564 shares — an estimated $9.34M sold.

Ergoteles first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $9.34M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Ergoteles reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Ergoteles sold 333,564 Intersect ENT, Inc shares in Q2 2022, an estimated $9.34M.
Ergoteles first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Ergoteles's Intersect ENT, Inc position peaked at $9.34M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.